multiorgan failure
[용어속성] Symptom
Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial
Clinical Trial
[키워드] 1:1
95% CI
acute illness
adverse event
affecting
assigned
AstraZeneca
atherosclerotic
benefit
cardiometabolic risk factor
cardiovascular disease
Chronic kidney disease
clinical recovery
clinical status
COVID-19
Critically ill
Dapagliflozin
death
dose
double-blind
dysregulated
hazard ratio
heart failure
hospitalised
hypertension
inhibitor
intention-to-treat
kidney
medication
multiorgan failure
occurred
organ
organ dysfunction
outcome
outcomes
Patient
patients treated
patients with COVID-19
phase 3 trial
Placebo
placebo-controlled
placebo-controlled trial
Primary outcome
Protective
randomised
Randomly
Registered
reported
risk reduction
Safety
Serious Adverse Events
statistically significant
the placebo group
Treatment
type 2 diabetes
were assessed
were excluded
with COVID-19
worsened
[DOI] 10.1016/S2213-8587(21)00180-7 PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1016/S2213-8587(21)00180-7 PMC 바로가기 [Article Type] Clinical Trial
Melatonin as a Potential Adjuvant Treatment for COVID-19 beyond Sleep Disorders
Review
[키워드] Activation
adjuvant
adverse effect
anti-SARS-CoV-2
cells
change
COVID-19
COVID-19 patients
COVID-19 progression
COVID-19 vaccination
Deterioration
Disease progression
disorder
Effect
Effects
Efficacy
Free radicals
hyper-inflammation
immune cells
inhibit
Insomnia
lack
limit
Lungs
melatonin
multiorgan failure
Patient
patients with COVID-19
physiological effects
Potential
preclinical data
randomized clinical trial
reduce
Registered
resulting
risk
safety profile
Sleep
Sleep disturbance
sleep quality
the SARS-CoV-2 virus
therapeutic option
tissue
treat
Treatment
Ventilator-induced lung injury
[DOI] 10.3390/ijms22168623 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/ijms22168623 PMC 바로가기 [Article Type] Review
Complete Heart Block as a Clinical Feature in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients: A Case Series of Three Cases
Case Series
[키워드] 24 hours
block
case sery
cause
CHB
clinical
Clinical characteristics
Complete heart block
coronary syndrome
COVID-19
COVID-19 patient
COVID-19 patients
Critically ill
diagnosed with COVID-19
disease
exhibited
Familial
heart
hemodynamic
hemodynamic instability
hypoxic respiratory failure
Ill
include
infiltration
intubation
Lower
male
mechanical ventilator
metabolic derangement
morbidity and mortality
multiorgan failure
Myocardial inflammation
novel
outcome
past medical history
patients with COVID-19
potential mechanism
potential mechanisms
pregnant
required
resolved
Section
Sery
Severe COVID-19 pneumonia
Shock
sinus pause
Support
with COVID-19
[DOI] 10.1155/2021/9955466 PMC 바로가기 [Article Type] Case Series
[DOI] 10.1155/2021/9955466 PMC 바로가기 [Article Type] Case Series
NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments
Pharmacology
[키워드] Antiviral
chromatin
conditions
COVID-19
Cytokine storm
death
Defense
element
Extracellular
extracellular trap
Host
implicated
infections
Inflammation
initial
involved
multiorgan failure
NETosis
NETs
neutrophil
pathogenesis of COVID-19
pathogenic
Potential
pro-inflammatory
procoagulant
promoted
Proteins
SARS-CoV-2
severe COVID-19 patients
severe SARS-CoV-2
System
target
Therapeutics
Treatment
[DOI] 10.3389/fphar.2021.708302 PMC 바로가기 [Article Type] Pharmacology
[DOI] 10.3389/fphar.2021.708302 PMC 바로가기 [Article Type] Pharmacology
In-hospital mortality among immunosuppressed patients with COVID-19: Analysis from a national cohort in Spain
Research Article
[키워드] 95% CI
acute respiratory distress
adjusted odds ratio
Cancer
Clinical characteristics
Cohort
COVID-19
death
evaluate
heart failure
hematologic
higher odd
Immunosuppressed
immunosuppressed patient
In-hospital
in-hospital complication
In-hospital death
laboratory-confirmed
Mortality
multicentre
multiorgan failure
multivariable logistic regression
myocarditis
National
organ
outcome
Patient
patients
patients hospitalized
patients with haematological
receiving
registry
Result
retrospective cohort study
Spain
syndrome
systemic steroids
thromboembolic disease
Treatment
with COVID-19
worse prognosis
[DOI] 10.1371/journal.pone.0255524 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0255524 PMC 바로가기 [Article Type] Research Article
Fatal septic shock due to Capnocytophaga canimorsus bacteremia masquerading as COVID-19 pneumonia – a case report
Covid -19 Pneumonia로 가장 한 Capnocytophaga Canimorsus Bacteremia로 인한 치명적인 패혈증 충격 - 사례 보고서
Case Reports
[키워드] acute phase
Acute respiratory failure
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Admission
Ag-RDT
Antigen
Bacteremia
Bacteria
Bacterial
Blood
Capnocytophaga
Capnocytophaga canimorsus
Case report
caused
characterized
Complication
consequence
Contact
contribute
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 pneumonia
Culture
cytokine
Cytokine storm
diagnosed
Diagnosis
diagnosis of COVID-19
diagnosis of SARS-CoV-2
diagnostic
diagnostic test
differential diagnose
differential diagnoses
Early detection
facilitated
false-positive result
False-positive results
fixation
hospital
hyperinflammation
ICU
Infection
Infectious disease
Infectious diseases
information
initial
Injury
intensive care unit
laboratory result
Laboratory results
male
microbial
multiorgan failure
NAAT
nucleic acid amplification
nucleic acid amplification test
occur
organ
outcome
Patient
Pneumonia
positive
Post-mortem
provide
Rapid antigen diagnostic test
referred to
respiratory
Respiratory failure
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 pandemic
Sepsis
Septic shock
severe acute respiratory syndrome Coronavirus
subsequent
Symptoms
the patient
therapy
Treatment
while
[DOI] 10.1186/s12879-021-06422-y PMC 바로가기 [Article Type] Case Reports
[DOI] 10.1186/s12879-021-06422-y PMC 바로가기 [Article Type] Case Reports
Outcomes of renal replacement therapy in the critically ill with COVID-19
Observational Study
[키워드] Acute kidney injury
adjusted
age
ARDS
association
C-reactive protein
Care
carried
Cohort
continuous venovenous hemofiltration
COVID-19
Critically ill
Critically ill patient
demographic
English
generate
high mortality
high mortality rate
hospital mortality rate
ICU
Illness severity
independent risk factor
laboratory data
logistic regression model
mechanical ventilation
mechanically ventilated
Mortality
multiorgan failure
outcome
Oxygen therapy
patients
prospective observational study
prospectivo
Reemplazo renal
renal
Renal replacement
renal replacement therapy
required
risk
SARD.
single-center
Spanish
therapy
variable
with COVID-19
[DOI] 10.1016/j.medine.2021.02.006 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1016/j.medine.2021.02.006 PMC 바로가기 [Article Type] Observational Study
Mechanics Insights of Alpha-Lipoic Acid against Cardiovascular Diseases during COVID-19 Infection
Review
[키워드] “cytokine storm”
ACE2
acid
Activation
acute respiratory syndrome
addition
alpha-lipoic acid
alveolar cells
Analysis
anti-inflammatory effect
antioxidant
appear
ARDS
binding
blood vessels
cardiovascular
cardiovascular comorbidity
cardiovascular disease
caused
cellular entry
Coagulopathy
complex
Complication
contribute
coronavirus
Coronavirus disease 2019
COVID-19
COVID-19 complications
COVID-19 infection
Critical
critical condition
death
distress
distribution
dysfunction
endothelial
Endothelial cell
Endothelial dysfunction
endothelial function
Endothelium
Evolution
expressed
global pandemic
high risk
homeostasis
human Angiotensin-converting enzyme
immune system
IMPROVE
independent
induce
infected with SARS-CoV-2
Infection
Inflammation
information
insight
interfere
lung
Mechanics
mechanism
microthrombi
mitochondrial
Mitochondrial function
multiorgan failure
Myocardial infarction
nitric oxide
oxidative stress
pathology
pathway
Patient
Perspective
predominant
Prognosis
proinflammatory
protease
Protein
reactive oxygen specy
receptor
redox status
reduced
reported
Respiratory disease
SARS-CoV-2
SARS-COV-2 infection
serine 2
severe COVID-19
signaling pathways
small intestine
Spread
stroke
the S protein
the SARS-CoV-2
therapeutic
therapy
thrombosis
tissue
TMPRSS2
transmembrane
underlying diseases
upregulation
viral infection
viral surface
virus
Wuhan, China
[DOI] 10.3390/ijms22157979 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/ijms22157979 PMC 바로가기 [Article Type] Review
SARS-CoV-2: is there neuroinvasion?
SARS-CoV-2: 신경 침범이 있습니까?
Review
[키워드] ACE2
ACE2 distribution
acute respiratory distress
acute respiratory distress syndrome
Affect
aging
Blood–brain barrier (BBB)
Brain
brains
breadth
Cerebrospinal fluid (CSF)
Choroid plexus
CNS
Complication
complications
conditions
Consensus
contribute
coronavirus
CoV
COVID-19
CSF
diabete
diabetes
disease
distress
distribution
Effects
Evidence
evidence of
flux
Health
health condition
help
hypertension
include
information
inhalation
Invasion
main receptor
male
mechanism
medical condition
MMP9
mucosa
multiorgan failure
neurological
Neurological complications
neurological manifestation
neurological manifestations
neurological problems
Neuron
neurons
obesity
Older
olfactory
outcome
outlined
parenchyma
pathway
Pathways
Patient
present
Replication
respiratory
respiratory distress
Respiratory distress syndrome
Respiratory system
route of infection
SARS-CoV-2
SARS-CoV-2 neuroinvasion
severely infected patients
significantly
syndrome
tissues
understanding
Vascular
vascular dysfunction
vessels
virus
while
[DOI] 10.1186/s12987-021-00267-y PMC 바로가기 [Article Type] Review
[DOI] 10.1186/s12987-021-00267-y PMC 바로가기 [Article Type] Review